Pay in 4 interest-free payments of $6.53 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
Absence of glucagon and insulin action reveals a role for the GLP-1 receptor in endogenous glucose production
Although ACTL6A has been characterized as an oncogene in many human cancers, its role in GC is unknown, and knowledge of the underlying mechanisms is limited
Dose selection in the research literature varies with the application: musculoskeletal-injury studies commonly report 200250 g twice daily near the affected site, while gastrointestinal-focused protocols use 250500 g once or twice daily, subcutaneously
doi: 10.34172/hpp.2020.50 240
US$ 23.59
US$ 21.71
US$ 20.47
US$ 26.86
US$ 25.82
US$ 27.91
US$ 29.09
US$ 28.80
US$ 25.68
US$ 21.37
